Go to
JCI Insight
Citations to this article
Nancy C. Andrews
Published May 1, 2004
Citation Information: J Clin Invest. 2004;113(9):1251-1253. https://doi.org/10.1172/JCI21441.
Citation Information: J Clin Invest. 2004;113(9):1251-1253. https://doi.org/10.1172/JCI21441.
Abstract
The anemia of inflammation, commonly observed in patients with chronic infections, malignancy, trauma, and inflammatory disorders, is a well-known clinical entity. Until recently, we understood little about its pathogenesis. It now appears that the inflammatory cytokine IL-6 induces production of hepcidin, an iron-regulatory hormone that may be responsible for most or all of the features of this disorder.
Authors
Nancy C. Andrews
Total citations by year
Citation information
Citations to this article in year 2017 (3)
| Title and authors | Publication | Year |
|---|---|---|
|
Identification of Guanosine 5′-diphosphate as Potential Iron Mobilizer: Preventing the Hepcidin-Ferroportin Interaction and Modulating the Interleukin-6/Stat-3 Pathway
S Angmo, N Tripathi, S Abbat, S Sharma, SS Singh, A Halder, K Yadav, G Shukla, R Sandhir, V Rishi, PV Bharatam, H Yadav, NK Singhal |
Scientific Reports | 2017 |
|
Vitamin D Status Is Associated with Hepcidin and Hemoglobin Concentrations in Children with Inflammatory Bowel Disease:
S Syed, ES Michalski, V Tangpricha, S Chesdachai, A Kumar, J Prince, TR Ziegler, PS Suchdev, S Kugathasan |
Inflammatory Bowel Diseases | 2017 |
|
Hamp1 but not Hamp2 regulates ferroportin in fish with two functionally distinct hepcidin types
JV Neves, MF Ramos, AC Moreira, T Silva, MS Gomes, PN Rodrigues |
Scientific Reports | 2017 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)